Perkins Coie Trust Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4K | Buy |
+90
| New | +$17.2K | ﹤0.01% | 212 |
|
|
2023
Q4 | – | Sell |
-22
| Closed | -$5.65K | – | 329 |
|
|
2023
Q3 | $5.65K | Buy |
22
+6
| +38% | +$1.6K | ﹤0.01% | 275 |
|
|
2023
Q2 | $4.56K | Hold |
16
| – | – | ﹤0.01% | 199 |
|
|
2023
Q1 | $4.45K | Hold |
16
| – | – | ﹤0.01% | 212 |
|
|
2022
Q4 | $4.43K | Hold |
16
| – | – | ﹤0.01% | 205 |
|
|
2022
Q3 | $4K | Hold |
16
| – | – | ﹤0.01% | 212 |
|
|
2022
Q2 | $3K | Hold |
16
| – | – | ﹤0.01% | 216 |
|
|
2022
Q1 | $3K | Hold |
16
| – | – | ﹤0.01% | 222 |
|
|
2021
Q4 | $4K | Sell |
16
-350
| -96% | -$90K | ﹤0.01% | 209 |
|
|
2021
Q3 | $104K | Hold |
366
| – | – | 0.03% | 110 |
|
|
2021
Q2 | $127K | Buy |
366
+16
| +5% | +$4.85K | 0.04% | 104 |
|
|
2021
Q1 | $98K | Hold |
350
| – | – | 0.03% | 113 |
|
|
2020
Q4 | $86K | Hold |
350
| – | – | 0.03% | 122 |
|
|
2020
Q3 | $99K | Hold |
350
| – | – | 0.04% | 110 |
|
|
2020
Q2 | $94K | Hold |
350
| – | – | 0.04% | 119 |
|
|
2020
Q1 | $111K | Hold |
350
| – | – | 0.06% | 108 |
|
|
2019
Q4 | $104K | Hold |
350
| – | – | 0.04% | 126 |
|
|
2019
Q3 | $81K | Hold |
350
| – | – | 0.04% | 139 |
|
|
2019
Q2 | $82K | Hold |
350
| – | – | 0.04% | 132 |
|
|
2019
Q1 | $83K | Hold |
350
| – | – | 0.04% | 128 |
|
|
2018
Q4 | $105K | Hold |
350
| – | – | 0.06% | 116 |
|
|
2018
Q3 | $124K | Hold |
350
| – | – | 0.06% | 114 |
|
|
2018
Q2 | $102K | Hold |
350
| – | – | 0.05% | 125 |
|
|
2018
Q1 | $96K | Sell |
350
-50
| -13% | -$15.5K | 0.05% | 128 |
|
|
2017
Q4 | $127K | Hold |
400
| – | – | 0.06% | 111 |
|
|
2017
Q3 | $125K | Hold |
400
| – | – | 0.06% | 109 |
|
|
2017
Q2 | $109K | Hold |
400
| – | – | 0.06% | 115 |
|
|
2017
Q1 | $109K | Hold |
400
| – | – | 0.06% | 102 |
|
|
2016
Q4 | $113K | Hold |
400
| – | – | 0.07% | 100 |
|
|
2016
Q3 | $125K | Hold |
400
| – | – | 0.08% | 92 |
|
|
2016
Q2 | $97K | Hold |
400
| – | – | 0.06% | 96 |
|
|
2016
Q1 | $104K | Hold |
400
| – | – | 0.07% | 95 |
|
|
2015
Q4 | $123K | Hold |
400
| – | – | 0.09% | 81 |
|
|
2015
Q3 | $117K | Hold |
400
| – | – | 0.09% | 82 |
|
|
2015
Q2 | $162K | Hold |
400
| – | – | 0.12% | 77 |
|
|
2015
Q1 | $169K | Hold |
400
| – | – | 0.13% | 75 |
|
|
2014
Q4 | $136K | Sell |
400
-124
| -24% | -$40.1K | 0.11% | 72 |
|
|
2014
Q3 | $173K | Buy |
524
+24
| +5% | +$7.91K | 0.15% | 68 |
|
|
2014
Q2 | $158K | Hold |
500
| – | – | 0.15% | 64 |
|
|
2014
Q1 | $153K | Sell |
500
-100
| -17% | -$31.7K | 0.15% | 64 |
|
|
2013
Q4 | $168K | Buy |
+600
| New | +$155K | 0.17% | 63 |
|
Other funds holding BIIB
Perkins Coie Trust Company's BIIB Position: Q2 2026 in Review
Perkins Coie Trust Company opened a new position in Biogen (BIIB) in Q2 2026: 90 shares worth $19.4K. The stake represents ﹤0.01% of the portfolio and ranks #212 among its holdings. This is a return to the name: Perkins Coie Trust Company previously reported a position in BIIB as recently as Q3 2023.
Perkins Coie Trust Company first reported a position in BIIB in Q4 2013 and has held it in 41 quarters since. The position peaked at $173K in Q3 2014. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Perkins Coie Trust Company held 90 shares of Biogen worth $19.4K as of Q2 2026.
- Biogen was a new Perkins Coie Trust Company position in Q2 2026.
- Biogen made up ﹤0.01% of Perkins Coie Trust Company's portfolio in Q2 2026, its #212 holding.
- Perkins Coie Trust Company first reported a position in Biogen in Q4 2013 and has held it in 41 quarters since.
- Perkins Coie Trust Company's Biogen position peaked at $173K in Q3 2014.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.